Асосий контентга ўтиш
AkademIndex

Маҳсулотлар

Ишлаб чиқувчилар учун

AkademBaseЭкотизим учун очиқ API

Prostate Cancer Treatment and Research

38 та иш

  1. SIGNIFICANCE OF THE T-34C POLYMORPHISM IN THE CYP17A1 GENE IN THE DEVELOPMENT OF BENIGN PROSTATIC HYPERPLASIA AND PROSTATE CANCER

    Mamarizaev, A.A., Azimova, S.B., Rustamov, U.M.

    МақолаProstate Cancer Treatment and ResearchZenodo (CERN European Organization for Nuclear Research)20250 иқтибос
    ABI

  2. SIGNIFICANCE OF THE T-34C POLYMORPHISM IN THE CYP17A1 GENE IN THE DEVELOPMENT OF BENIGN PROSTATIC HYPERPLASIA AND PROSTATE CANCER

    Mamarizaev, A.A., Azimova, S.B., Rustamov, U.M.

    МақолаProstate Cancer Treatment and ResearchZenodo (CERN European Organization for Nuclear Research)20250 иқтибос
    ABI

  3. THE ROLE OF A KEY ANDROGEN-METABOLIZING GENE IN THE DEVELOPMENT AND EARLY DETECTION OF PROSTATE CANCER

    Mamarizaev, A.A., Azimova, S.B., Rustamov, U.M.

    МақолаProstate Cancer Treatment and ResearchZenodo (CERN European Organization for Nuclear Research)20250 иқтибос
    ABI

  4. THE ROLE OF A KEY ANDROGEN-METABOLIZING GENE IN THE DEVELOPMENT AND EARLY DETECTION OF PROSTATE CANCER

    Mamarizaev, A.A., Azimova, S.B., Rustamov, U.M.

    МақолаProstate Cancer Treatment and ResearchZenodo (CERN European Organization for Nuclear Research)20250 иқтибос
    ABI

  5. IMPACT OF ANDROGEN DEPRIVATION MODALITIES ON SURVIVAL AND QUALITY OF LIFE IN ADVANCED PROSTATE CANCER

    Ibrohim Faxriddinovich Yodgorov

    МақолаProstate Cancer Treatment and ResearchZenodo (CERN European Organization for Nuclear Research)20260 иқтибос
    ABI

  6. IMPACT OF ANDROGEN DEPRIVATION MODALITIES ON SURVIVAL AND QUALITY OF LIFE IN ADVANCED PROSTATE CANCER

    Ibrohim Faxriddinovich Yodgorov

    МақолаProstate Cancer Treatment and ResearchZenodo (CERN European Organization for Nuclear Research)20260 иқтибос
    ABI

  7. CONTEMPORARY APPROACHES TO HORMONAL THERAPY IN MALIGNANT PROSTATE TUMORS

    Ibrohim Faxriddinovich Yodgorov

    МақолаProstate Cancer Treatment and ResearchZenodo (CERN European Organization for Nuclear Research)20260 иқтибос
    ABI

  8. CONTEMPORARY APPROACHES TO HORMONAL THERAPY IN MALIGNANT PROSTATE TUMORS

    Ibrohim Faxriddinovich Yodgorov

    МақолаProstate Cancer Treatment and ResearchZenodo (CERN European Organization for Nuclear Research)20260 иқтибос
    ABI

  9. CTLA-4: a promising immunosuppressive immune checkpoint in prostate cancer therapy

    Nada Khairi Younis, Ali Fawzi Al-Hussainy, S. Renuka Jyothi +7

    МақолаCancer Immunotherapy and BiomarkersClinical & Translational Oncology20260 иқтибос
    ABI

  10. EVALUATION OF THE EFFICIENCY OF COMBINED TREATMENT OF PATIENTS WITH BONE METASTASES FROM KIDNEY AND PROSTATE CANCER USING SYSTEMIC RADIATION AND TARGETED THERAPY

    N.M. Rakhimov, Sh.Sh. Shakhanova

    МақолаBone health and treatmentsAvicenna Bulletin20260 иқтибос
    ABI

  11. PALLADIUM-103 -LABELED PSMA RADIOTRACER FOR AUGER ELECTRON THERAPY OF PROSTATE CANCER METASTASES

    Aleksander Bilewicz, Magda Piątkowska, Monika Łyczko +4

    МақолаProstate Cancer Treatment and ResearchEANM Innovation20260 иқтибос
    ABI

  12. Deintegration of Coordination Nodes: An Evolutionary Approach to Radiotherapy of High-Risk Prostate Cancer (Gleason 8+)

    Anatoliy Kremenchutskiy

    ПрепринтMathematical Biology Tumor GrowthZenodo (CERN European Organization for Nuclear Research)20260 иқтибос
    ABI

  13. Deintegration of Coordination Nodes: An Evolutionary Approach to Radiotherapy of High-Risk Prostate Cancer (Gleason 8+)

    Anatoliy Kremenchutskiy

    ПрепринтMathematical Biology Tumor GrowthZenodo (CERN European Organization for Nuclear Research)20260 иқтибос
    ABI